Jury still out on real value of remote patient monitoring

Cancer mortality rates have decreased by 34% overall, but incidence rates for women of all ages continue to rise, according to a new report from the American Cancer Society.

Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.

Berge will serve in this role through the end of 2026, marking another milestone in her successful career in healthcare.

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.

Will the Stelara biosimilars be a reprise of the Humira biosimilars in 2023 and be slow to catch on?

Lyle Berkowitz, M.D., CEO of KeyCare, gives a prediction for 2025.